Latest News
- Events
- News
- Press
- Uncategorized
- View all
TreeFrog Presents Data From Their Parkinson’s Disease Cell Therapy Program At The 29th World Congress On Parkinson’s Disease And Related Disorders (IAPRD) In Lisbon TreeFrog Presents Data From Their Parkinson’s Disease Cell Therapy Program At The 29th World Congress On Parkinson’s Disease And Related Disorders (IAPRD) In Lisbon TreeFrog May 20, 2024
Vertex and TreeFrog Therapeutics Announce Licensing Agreement and Collaboration to Optimize Production of Vertex’s Cell Therapies for Type 1 Diabetes Vertex and TreeFrog Therapeutics Announce Licensing Agreement and Collaboration to Optimize Production of Vertex’s Cell Therapies for Type 1 Diabetes TreeFrog April 23, 2024
TreeFrog Presents Data From Their Parkinson’s Cell Therapy Program At The American Academy Of Neurology Annual Meeting TreeFrog Presents Data From Their Parkinson’s Cell Therapy Program At The American Academy Of Neurology Annual Meeting TreeFrog April 15, 2024
TreeFrog Therapeutics reinforces Executive Committee with three new members TreeFrog Therapeutics reinforces Executive Committee with three new members. TreeFrog November 9, 2023
Our blog “In the Stem Cell Jungle” is out TreeFrog February 14, 2023
3 PhD students from King’s College London win the $100,000 Stem Cell SpaceShot grant TreeFrog October 20, 2022
TreeFrog Therapeutics moves to GMP manufacturing with cell encapsulation device delivered by Invetech The machine will be transferred in 2023 to a contract development and manufacturing organization (CDMO) to produce TreeFrog’s cell therapy candidate for Parkinson’s disease, with the aim of a first-in-human trial in 2024. Over 2023, Invetech will deliver three additional GMP encapsulation devices to support TreeFrog’s in-house and partnered cell therapy programs in regenerative medicine and immuno-oncology. TreeFrog October 11, 2022
10 International Scientists Nominated For The $100,000 Stem Cell SpaceShot Grant TreeFrog August 30, 2022
Peter Nell joins TreeFrog Therapeutics as Independent Board Member TreeFrog July 25, 2022
See Also
Vertex and TreeFrog Therapeutics Announce Licensing Agreement and Collaboration to Optimize Production of Vertex’s Cell Therapies for Type 1 Diabetes - Treefrog TherapeuticsUmoja Biopharma and TreeFrog Therapeutics Announce Collaboration to Address Current Challenges Facing Ex Vivo Allogeneic Therapies in Immuno-Oncology | Umoja BiopharmaCell Therapy Pipeline I iPS-derived Cell Therapies I Allogeneic Stem Cell TherapiesVERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES Umoja Biopharma and TreeFrog Therapeutics announce collaboration to address current challenges facing ex vivo allogeneic therapies in immuno-oncology TreeFrog June 10, 2022
TreeFrog Therapeutics launches a $100,000 research grant in regenerative medicine TreeFrog April 19, 2022
TreeFrog Therapeutics expands Board with new independent members from the cell therapy industry TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and gene editing, the newly created SAB will guide the development of proprietary C-StemTM technology platform and in-house cell therapy programs. TreeFrog April 14, 2022
TreeFrog Therapeutics opens technological hub in Kobe, Japan, to drive partnerships opportunities in the field of iPSC-derived cell therapies TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and gene editing, the newly created SAB will guide the development of proprietary C-StemTM technology platform and in-house cell therapy programs. TreeFrog April 8, 2022
EIC ScalingUp TOP50: TreeFrog Therapeutics selected among 3,000 European Deeptech companies TreeFrog April 1, 2022
Happy 2022 from the Froggies (showcasing our egg/chicken/dino dance moves) ! The whole team at TreeFrog Therapeutics wishes you a Happy New Year ! TreeFrog December 21, 2021
TreeFrog celebrates its third birthday, announcing a two-fold increase in lab capacity ! TreeFrog Therapeutics celebrated its 3rd anniversary on December 7th, 2021, announcing that the company increase its clean room capacity by two-fold in Pessac, to support its acceleration in cell therapy. TreeFrog December 7, 2021
Leap forward in cell therapy manufacturing: data reveals highly reproducible stem cell expansion in 10L bioreactors, with exponential growth and preserved quality TreeFrog June 21, 2021
World first: TreeFrog Therapeutics announces the production of a single batch of 15 billion iPS cells in a 10L bioreactor with exponential amplification of 276-fold per week. TreeFrog April 12, 2021
Christmas is here: our first 3 contracts signed in Q4 2020 ! TreeFrog December 23, 2020
Happy New Year from the Froggies (with our best Christmas sweaters) ! The whole team at TreeFrog Therapeutics wishes you a Happy New Year ! TreeFrog December 21, 2020
The French Blood Agency announces agreement with TreeFrog Therapeutics to scale-up manufacturing of iPS-derived hematopoietic stem cell transplants TreeFrog November 17, 2020
TreeFrog nominated for the Prix Galien MedStartup Award ! TreeFrog September 22, 2020
TreeFrog is now a team of 30+ TreeFrog September 15, 2020
TreeFrog joins the Japanese Society for Regenerative Medicine TreeFrog June 18, 2020
360° video of our first industrial site ! TreeFrog June 10, 2020
Labiotech.eu announces the launch of our new facility ! TreeFrog
Press Release : TreeFrog Therapeutics opens its first facility dedicated to iPS cell therapy scale-up in Bordeaux, France TreeFrog June 9, 2020
C-Stem™ technology presented in London TreeFrog February 10, 2020
TreeFrog in Tokyo! TreeFrog February 6, 2020
TreeFrog in Le Monde ! TreeFrog January 31, 2020
C-Stem presented at the FSSCR annual meeting in Lyon ! TreeFrog November 20, 2019
TreeFrog named Deep Tech Pioneer TreeFrog
TreeFrog in Boston ! TreeFrog October 31, 2019
TreeFrog’s CTO interviewed by BioProcess International TreeFrog September 30, 2019
Successful Cell Therapy Roadtrip in Japan ! TreeFrog September 20, 2019
Press release : TreeFrog Therapeutics receives additional €3M non-dilutive funding TreeFrog September 5, 2019
Cell therapy roadtrip in Japan TreeFrog September 3, 2019
TreeFrog’s CEO/CTO cited in Labiotech.eu TreeFrog May 29, 2019
La Tribune : “In Bordeaux, TreeFrog Therapeutic raises 7,1 M€” TreeFrog May 13, 2019
Labiotech.eu : Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks TreeFrog
TreeFrog Therapeutics raises over €7M ($7.8M) TreeFrog
Meet us in London on May 16-17 TreeFrog May 7, 2019
Press release : TreeFrog Therapeutics delivers first batch of Stem Cells (hIPS), with best in class quality check, to cell and gene therapy leader Imagine Institute TreeFrog April 15, 2019
Treefrog Therapeutics featured in Sud Ouest TreeFrog March 22, 2019
Our licensing agreement covered by La Tribune ! TreeFrog
Website “Genethique” about TreeFrog’s iPS mass-production technology TreeFrog March 20, 2019
La Recherche just published an article about Treefrog Therapeutics TreeFrog March 19, 2019
Treefrog Therapeutics cited in Les Echos TreeFrog January 14, 2019
La Tribune announces our seed funding TreeFrog January 10, 2019
Press Release : TreeFrog announces regional seed round of 600k€ TreeFrog January 9, 2019
NECTAR 2018: Erwan Bezard will present TreeFrog’s cell therapy programme for Parkinson’s disease TreeFrog November 30, 2018
TreeFrog Therapeutics appoints Jean-Luc Treillou as Chairman of the Board TreeFrog November 28, 2018
New article in La Tribune TreeFrog July 6, 2018
TreeFrog wins the i-LAB innovation contest TreeFrog July 5, 2018
Ressources
Explore our resources to learn more
Please visit our resources section for insightful Stem Cell Blog entries, articles, publications, and much more.
Contact
